Brief: Aarti Drugs Says SEBI Issues Administrative Warning To Co's Compliance Officer, Company Secretary
06/03/2025 15:24
March 6 (Reuters) - Aarti Drugs Ltd ADRG.NS: AARTI DRUGS LTD - SEBI ISSUES ADMINISTRATIVE WARNING TO CO'S COMPLIANCE OFFICER, COMPANY SECRETARY AARTI DRUGS LTD - NO IMPACT ON FINANCIAL, OPERATIONAL OR OTHER ACTIVITIES Source text: ID:nBSE1T64wJ Further company coverage: ADRG.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees